# Bioequivalence Study of Ivermectin 1% Cream and Soolantra (Ivermectin) 10 mg/g Cream

> **NCT06557603** · PHASE1 · COMPLETED · sponsor: **Humanis Saglık Anonim Sirketi** · enrollment: 44 (actual)

## Conditions studied

- Rosacea

## Interventions

- **DRUG:** Ivermectin cream
- **DRUG:** Soolantra ® (Ivermectin) cream

## Key facts

- **NCT ID:** NCT06557603
- **Lead sponsor:** Humanis Saglık Anonim Sirketi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-03-06
- **Primary completion:** 2024-07-11
- **Final completion:** 2024-07-22
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2024-08-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06557603

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06557603, "Bioequivalence Study of Ivermectin 1% Cream and Soolantra (Ivermectin) 10 mg/g Cream". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06557603. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*